Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.
Meldrum
B
B
D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D001224:Aspartic Acid / Q000037:antagonists & inhibitors* / Q000502:physiology; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D001921:Brain / Q000378:metabolism; D002545:Brain Ischemia / Q000188:drug therapy*; D004827:Epilepsy / Q000188:drug therapy*; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates / Q000502:physiology; D018698:Glutamic Acid; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D051379:Mice; D009069:Movement Disorders / Q000188:drug therapy*; D009410:Nerve Degeneration; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors* / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy; D051381:Rats
D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates; D018377:Neurotransmitter Agents; D001224:Aspartic Acid; D018698:Glutamic Acid